Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 175 results found. Search for [ Zydus coronavirus vaccine ]

Results 40 to 60 of 175
BusinessToday.In
October 4, 2020
COVID-19 vaccine update: The Centre is deliberating allowing companies to secure vaccine doses directly and early on to ensure that there is no disruption of key economic activities


BusinessToday.In
October 3, 2020
COVID-19 vaccine: A principal investigator from a trial site in Maharashtra said that they are expecting to finish enrolling the participants within the next two months after which they will be monitored for the vaccine's efficacy


BusinessToday.In
October 2, 2020
Coronavirus cases in India: The active patients' tally in India stands at 9,42,217; around 53,52,078 patients have recovered and 99,773 have succumbed to the deadly virus so far


BusinessToday.In
October 1, 2020
Coronavirus vaccine update: In India, there are three COVID-19 vaccines under human trials--Bharat Biotech's COVAXIN, Oxford's COVDSHIELD, and Zydus Cadila's ZyCoV-D. Serum Institute has already begun a phase-3 trial of Oxford vaccine candidates at 17 sites


BusinessToday.In
September 30, 2020
COVID-19 vaccine being developed by AstraZeneca-Oxford University, Novavax, Moderna, Pfizer Inc and Johnson & Johnson are already in an advanced stage of testing


BusinessToday.In
September 28, 2020
The government is going to assess efficacy data of all concerned companies (working on COVID-19 vaccines) before inking a purchase contract with them and will buy vaccines at least for essential workers


BusinessToday.In
September 24, 2020
India Stock Market Highlights Today: All Sensex components were in the red with M&M, Bajaj Finance, IndusInd Bank, Maruti, Axis Bank, Bajaj Finserv and ICICI Bank shedding up to 33%.


BusinessToday.In
September 22, 2020
Gagandeep Kang, professor of microbiology at Christian Medical College said that by year-end, data on which vaccine candidate is working and which not will be made available


BusinessToday.In
September 17, 2020
Addressing the Rajya Sabha over the coronavirus situation in the country, Dr. Harsh Vardhan said that India is also making efforts like other nations, adding that \"three vaccine candidates are in different phases\" of clinical trials


BusinessToday.In
September 15, 2020
COVID-19 vaccine candidates being developed by Cadila Healthcare and Bharat Biotech have completed the phase one of the study while Pune-based Serum Institute of India (SII) will begin with Phase 3 clinical trial after getting regulatory nod, says ICMR chief


BusinessToday.In
September 13, 2020
Union Health Minister Harsh Vardhan on Sunday said that he will be the first person to take COVID-19 vaccine so as to dispel the \"trust deficit\" around the same


BusinessToday.In
September 12, 2020
Bharat Biotech says its vaccine candidate was found to generate \"robust immune responses\", thus preventing infection and disease in primates upon high amounts of exposure to live SARS-CoV-2 virus


PB Jayakumar
September 9, 2020
Serum has also started manufacturing the vaccine, targeting to use in India and 92 other countries upon completion of trials and regulatory clearances


BusinessToday.In
September 9, 2020
Dr VK Paul informed the Russian government has approached India to facilitate the Phase-3 trial of their vaccine and also manufacture Sputnik V through Indian companies


PB Jayakumar
September 3, 2020
WHO's recommendation is based on three new studies, plus four other earlier trials, all involving a drug from the family of corticosteroids


BusinessToday.In
August 23, 2020
Initially, the ICMR vaccine portal will disseminate information on coronavirus vaccine in India. However, with time, data available for all the vaccines will be added to the portal


PB Jayakumar
August 22, 2020
Centre has sought 68 crore doses for 130 crore Indian citizens from Serum Institute by June, next year


BusinessToday.In
August 21, 2020
Coronavirus vaccine update: Serum Institute of India that is manufacturing the Oxford University-AstraZeneca vaccine will conductt the trials wouldon 1,600 healthy volunteers with no history of COVID-19


BusinessToday.In
August 19, 2020
Coronavirus vaccine news update: Oxford vaccine could be the first antidote to be released in India. Bharat Biotech's COVAXIN and Zydus Cadila's ZyCoV-D are in initial stages of trials


BusinessToday.In
New Delhi, August 19, 2020
COVID-19 pandemic: WHO lambasts 'vaccine nationalism' in last-resort attempt against hoardingNations that hoard possible COVID-19 vaccines while excluding others will deepen the pandemic, World Health Organization (WHO) chief Tedros Adhanom Ghebreyesus said on Tuesday, issuing a last-ditch call for countries to join a global vaccine pact. The WHO has an Aug. 31 deadline for wealthier nations to join the \"COVAX Global Vaccines Facility\" for sharing vaccine hopefuls with developing countries...


PAGES 3 OF 9  12345